firsekibart
firsekibart: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: GH Research PLC (GHRS)
Development Pipeline (1)
| Company | Phase |
|---|---|
| GH Research PLC (GHRS) | Phase 4 |
Clinical Trials (1)
Efficacy and Safety of IL-1 Inhibitors in the Treatment of Mild to Moderate Systemic Lupus Erythematosus With Inadequate Response to Conventional Therapy: A Single-Centre, Single-Arm, Pilot Study
Frequently asked questions
Who is developing firsekibart?
firsekibart is being developed by GH Research PLC.
How many clinical trials involve firsekibart?
BioSniper tracks 1 clinical trial involving firsekibart.
Analyze GH Research PLC & firsekibart with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company